Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Depreciation & Amortization (CF) (2021 - 2025)

Rxo (RXO) has disclosed Depreciation & Amortization (CF) for 4 consecutive years, with $28.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 15.15% year-over-year to $28.0 million, compared with a TTM value of $116.0 million through Dec 2025, up 33.33%, and an annual FY2025 reading of $116.0 million, up 33.33% over the prior year.
  • Depreciation & Amortization (CF) was $28.0 million for Q4 2025 at Rxo, up from $26.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $33.0 million in Q4 2024 and bottomed at $15.0 million in Q4 2023.
  • Average Depreciation & Amortization (CF) over 4 years is $22.2 million, with a median of $21.0 million recorded in 2022.
  • The sharpest move saw Depreciation & Amortization (CF) tumbled 30.43% in 2023, then skyrocketed 120.0% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $21.0 million in 2022, then fell by 28.57% to $15.0 million in 2023, then soared by 120.0% to $33.0 million in 2024, then dropped by 15.15% to $28.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for RXO at $28.0 million in Q4 2025, $26.0 million in Q3 2025, and $30.0 million in Q2 2025.